Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug Use Investigation of Jzoloft

Next Previous
X
Search
Trial Profile

Drug Use Investigation of Jzoloft

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sertraline (Primary)
  • Indications Anxiety disorders; Depressive disorders
  • Focus Adverse reactions
  • Sponsors Pfizer

    • Most Recent Events

    • 01 Feb 2021 This trial was completed in 2011 only and now the recent update in NCT00605865 and NCT00605813 reported that "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.". As per the source "https://investors.pfizer.com/investor-news/press-release-details/2020/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan/default.aspx, both merged and formed Viatris in Nov 2020. So I am not adding Viatris to associations, as its affiliation for this trial is not clear.
    • 11 Oct 2011 Actual trial end date (Sep 2011) added as reported by ClinicalTrials.gov (Parent trial: NCT00605865).
    • 11 Oct 2011 Actual trial end date (Sep 2011) added as reported by ClinicalTrials.gov (Parent trial: NCT00605865).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top